• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿型庞贝病长期幸存者的认知和学业成果:一项纵向随访研究

Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up.

作者信息

Spiridigliozzi Gail A, Keeling Lori A, Stefanescu Mihaela, Li Cindy, Austin Stephanie, Kishnani Priya S

机构信息

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.

Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.

出版信息

Mol Genet Metab. 2017 Jun;121(2):127-137. doi: 10.1016/j.ymgme.2017.04.014. Epub 2017 May 1.

DOI:10.1016/j.ymgme.2017.04.014
PMID:28495044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5985833/
Abstract

This study examines the long-term cognitive and academic outcomes of 11 individuals with infantile onset Pompe disease (IOPD) (median age=11years, 1month, range=5years, 6months through 17years of age) treated with enzyme replacement therapy from an early age. All participants (7 males, 4 females) were administered individual intelligence tests (Wechsler or Leiter scales or both), a measure of their academic skill levels (Woodcock-Johnson Tests of Achievement), and a screening measure of visual-motor integration ability (Beery-Buktenica). Consistent with our earlier findings, median IQ scores for the entire group on the Wechsler (median=84) and Leiter (median=92) scales continue to fall at the lower end of the average range compared to same-aged peers. The median scores for the group on a measure of visual-motor integration (median=76), visual perception (median=74) and motor coordination (median=60) were below average. Two distinct subgroups emerged based on participants' average or below average performance on the majority of academic subtests. Those participants with below average academic skills (n=6) demonstrated average nonverbal cognitive abilities on the Leiter, but had weaknesses in speech and language skills and greater medical involvement. Their profiles were more consistent with a learning disability diagnosis than an intellectual disability. Two of these participants showed a significant decline (15 and 23 points, respectively) on repeated Wechsler scales, but one continued to earn average scores on the Leiter scales where the verbal and motor demands are minimal. Participants with average academic skills (n=5) demonstrated average cognitive abilities (verbal and nonverbal) on the Wechsler scales and less medical involvement. Their speech and language skills appeared to be more intact. However, both groups earned below average median scores on the Beery-Buktenica motor coordination task. This study highlights the importance of using appropriate tests to capture both verbal and nonverbal abilities, considering each individual's motor skills, speech and language abilities, hearing status and native language. This will allow for a more accurate assessment of whether there is a learning disability or an intellectual disability. Long-term outcomes may be related to the stability of an individual's expressive and/or receptive language abilities over time. Changes in the speech and language domain may account for the decline in IQ observed in some IOPD long-term survivors, reflecting a learning disability rather than a decline in overall cognition or an intellectual disability. These observations, in conjunction with neuroimaging, will further our understanding of the neurocognitive profile of long-term IOPD survivors.

摘要

本研究考察了11例自幼接受酶替代疗法治疗的婴儿型庞贝病(IOPD)患者(中位年龄 = 11岁1个月,范围 = 5岁6个月至17岁)的长期认知和学业成果。所有参与者(7名男性,4名女性)均接受了个体智力测试(韦氏或莱特量表或两者皆有)、学业技能水平测量(伍德库克 - 约翰逊成就测验)以及视觉 - 运动整合能力筛查测量(贝里 - 布克滕尼卡测试)。与我们早期的研究结果一致,与同龄同龄人相比,整个组在韦氏量表(中位数 = 84)和莱特量表(中位数 = 92)上的智商中位数分数仍处于平均范围的较低端。该组在视觉 - 运动整合测量(中位数 = 76)、视觉感知(中位数 = 74)和运动协调(中位数 = 60)方面的中位数分数均低于平均水平。根据参与者在大多数学业子测试中的平均或低于平均表现,出现了两个不同的亚组。那些学业技能低于平均水平的参与者(n = 6)在莱特量表上表现出平均的非言语认知能力,但在言语和语言技能方面存在弱点,且医疗介入较多。他们的情况更符合学习障碍的诊断,而非智力障碍。其中两名参与者在重复的韦氏量表上出现了显著下降(分别下降了15分和23分),但有一名参与者在言语和运动要求最低的莱特量表上继续获得平均分数。学业技能平均的参与者(n = 5)在韦氏量表上表现出平均的认知能力(言语和非言语),且医疗介入较少。他们的言语和语言技能似乎更完整。然而,两组在贝里 - 布克滕尼卡运动协调任务中的中位数分数均低于平均水平。本研究强调了使用适当测试来获取言语和非言语能力的重要性,同时要考虑到每个人的运动技能、言语和语言能力、听力状况以及母语。这将有助于更准确地评估是否存在学习障碍或智力障碍。长期结果可能与个体表达性和/或接受性语言能力随时间的稳定性有关。言语和语言领域的变化可能解释了一些IOPD长期存活者中观察到的智商下降,这反映的是学习障碍,而非整体认知能力下降或智力障碍。这些观察结果与神经影像学相结合,将加深我们对IOPD长期存活者神经认知特征的理解。

相似文献

1
Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up.婴儿型庞贝病长期幸存者的认知和学业成果:一项纵向随访研究
Mol Genet Metab. 2017 Jun;121(2):127-137. doi: 10.1016/j.ymgme.2017.04.014. Epub 2017 May 1.
2
Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up.婴儿型庞贝病患儿接受酶替代疗法治疗后的认知和适应功能:长期随访。
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):22-9. doi: 10.1002/ajmg.c.31323. Epub 2012 Jan 17.
3
Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy.经典婴儿型庞贝病患者接受酶治疗的认知结果。
Neurology. 2012 May 8;78(19):1512-8. doi: 10.1212/WNL.0b013e3182553c11. Epub 2012 Apr 25.
4
Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.替代型阿糖苷酶α方案治疗庞贝病的安全性和有效性
Neuromuscul Disord. 2015 Apr;25(4):321-32. doi: 10.1016/j.nmd.2014.12.004. Epub 2014 Dec 19.
5
Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes.支气管肺发育不良和极低出生体重的认知及学业后果:8岁时的结局
Pediatrics. 2003 Nov;112(5):e359. doi: 10.1542/peds.112.5.e359.
6
Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease.婴儿起病庞贝病部分长期治疗儿童中严重中枢神经系统受累。
Mol Genet Metab. 2024 Feb;141(2):108119. doi: 10.1016/j.ymgme.2023.108119. Epub 2023 Dec 22.
7
Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.39个月时的视觉、认知和语言评估:一项针对1岁前喂食含长链多不饱和脂肪酸配方奶儿童的随访研究。
Pediatrics. 2003 Sep;112(3 Pt 1):e177-83. doi: 10.1542/peds.112.3.e177.
8
Early cognitive development in children with infantile Pompe disease.婴儿型庞贝病患儿的早期认知发育。
Mol Genet Metab. 2012 Mar;105(3):428-32. doi: 10.1016/j.ymgme.2011.10.012. Epub 2011 Oct 28.
9
Longitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease.对早发型庞贝病早期治疗患者进行言语障碍评估的纵向随访。
Eur J Paediatr Neurol. 2017 May;21(3):485-493. doi: 10.1016/j.ejpn.2016.12.004. Epub 2016 Dec 19.
10
Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning.经典婴儿型庞贝病患者的长期生存揭示了一种具有进行性脑异常和认知功能变化的谱。
J Inherit Metab Dis. 2024 Jul;47(4):716-730. doi: 10.1002/jimd.12736. Epub 2024 Apr 8.

引用本文的文献

1
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease.庞贝病中精准医学、遗传学、表观遗传学和人工智能的亮点
Int J Mol Sci. 2025 Jan 17;26(2):757. doi: 10.3390/ijms26020757.
2
Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease.婴儿起病庞贝病部分长期治疗儿童中严重中枢神经系统受累。
Mol Genet Metab. 2024 Feb;141(2):108119. doi: 10.1016/j.ymgme.2023.108119. Epub 2023 Dec 22.
3
Long-Term Outcome of Infantile Onset Pompe Disease Patients Treated with Enzyme Replacement Therapy - Data from a German-Austrian Cohort.婴儿期起病庞贝病患者接受酶替代治疗的长期预后 - 来自德奥队列的数据。
J Neuromuscul Dis. 2024;11(1):167-177. doi: 10.3233/JND-230164.
4
Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease.神经丝轻链及其与经典婴儿型庞贝病患者中枢神经系统受累的关系。
Neurology. 2023 Aug 8;101(6):e594-e601. doi: 10.1212/WNL.0000000000207482. Epub 2023 Jun 19.
5
[Research progress of nervous system damage in Pompe disease].庞贝病神经系统损害的研究进展
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Apr 15;25(4):420-424. doi: 10.7499/j.issn.1008-8830.2211052.
6
Visual-motor integration scale for Korean elderly (VMIS-KE) is an effective indicator for cognitive changes in diabetic older adults.韩国老年人视觉运动整合量表(VMIS-KE)是糖尿病老年人认知变化的有效指标。
J Exerc Rehabil. 2022 Oct 26;18(5):318-323. doi: 10.12965/jer.2244348.174. eCollection 2022 Oct.
7
Neuromuscular Development and Disease: Learning From and Models.神经肌肉发育与疾病:借鉴与模型
Front Cell Dev Biol. 2021 Oct 27;9:764732. doi: 10.3389/fcell.2021.764732. eCollection 2021.
8
Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and Adolescents.评估神经肌肉疾病中的认知功能:一项针对儿童和青少年样本的初步研究。
J Clin Med. 2021 Oct 18;10(20):4777. doi: 10.3390/jcm10204777.
9
Assessment of Dysphonia in Children with Pompe Disease Using Auditory-Perceptual and Acoustic/Physiologic Methods.使用听觉感知和声学/生理学方法评估庞贝病患儿的发声障碍
J Clin Med. 2021 Aug 16;10(16):3617. doi: 10.3390/jcm10163617.
10
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy.婴儿期起病庞贝病患者早期酶替代治疗后的听力特征。
Orphanet J Rare Dis. 2021 Aug 5;16(1):348. doi: 10.1186/s13023-021-01817-1.

本文引用的文献

1
Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy.婴儿型庞贝病患者接受酶替代治疗的神经影像学表现。
Mol Genet Metab. 2018 Feb;123(2):85-91. doi: 10.1016/j.ymgme.2017.10.005. Epub 2017 Oct 13.
2
Cognitive Development in Infantile-Onset Pompe Disease Under Very Early Enzyme Replacement Therapy.婴儿型庞贝病在极早期酶替代治疗下的认知发展
J Child Neurol. 2016 Dec;31(14):1617-1621. doi: 10.1177/0883073816665549. Epub 2016 Sep 21.
3
Cognitive decline in classic infantile Pompe disease: An underacknowledged challenge.经典型婴儿庞贝病中的认知衰退:一个未得到充分认识的挑战。
Neurology. 2016 Mar 29;86(13):1260-1. doi: 10.1212/WNL.0000000000002523. Epub 2016 Mar 4.
4
Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes.婴儿型庞贝病的极早期治疗有助于获得更好的预后。
J Pediatr. 2016 Feb;169:174-80.e1. doi: 10.1016/j.jpeds.2015.10.078. Epub 2015 Dec 10.
5
Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.新生儿筛查诊断、并从出生开始治疗的婴儿起病庞贝病患者的长期预后。
J Pediatr. 2015 Apr;166(4):985-91.e1-2. doi: 10.1016/j.jpeds.2014.10.068. Epub 2014 Nov 4.
6
New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond.庞贝病的新治疗方法:酶替代疗法及其他。
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:114-24.
7
Inborn errors of metabolism: combining clinical and radiologic clues to solve the mystery.先天性代谢缺陷:结合临床和影像学线索解开谜团。
AJR Am J Roentgenol. 2014 Sep;203(3):W315-27. doi: 10.2214/AJR.13.11154.
8
Imaging manifestations of the leukodystrophies, inherited disorders of white matter.脑白质营养不良的影像学表现,即白质的遗传性疾病。
Radiol Clin North Am. 2014 Mar;52(2):279-319. doi: 10.1016/j.rcl.2013.11.008.
9
Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy.经典婴儿型庞贝病患者接受酶治疗的认知结果。
Neurology. 2012 May 8;78(19):1512-8. doi: 10.1212/WNL.0b013e3182553c11. Epub 2012 Apr 25.
10
Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up.婴儿型庞贝病患儿接受酶替代疗法治疗后的认知和适应功能:长期随访。
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):22-9. doi: 10.1002/ajmg.c.31323. Epub 2012 Jan 17.